CFTR and cystic fibrosis: To date, one single molecule and three combinations of CFTR modulators have been approved for PwCF carrying specific CF-causing variants: potentiator ivacaftor (VX-770) as a single agent or in combinations with correctors lumacaftor (VX-809), tezacaftor (VX-661), and elexacaftor (VX-445).